Linezolid to treat MDR-/XDR-tuberculosis: available evidence and future scenarios

New experimental evidence on anti-TB regimes based on low-efficacious linezolid dosage to treat XDR-TB patients

Download the article from here.


Source: European Respiratory Journal

To subscribe to the Weekly Newsletter of new posts, enter your email here:


News

By Giovanni Sotgiu, Emanuele Pontali and Giovanni Battista Migliori

Published: Jan. 7, 2015, 4:07 p.m.

Last updated: Jan. 7, 2015, 5:18 p.m.

Print Share